Du Pont builds stable of partnersby forging PACS link with Olicon
Olicon awaits outcome of Du Pont divestitureDu Pont has expanded its strategy of gaining PACS expertise throughpartnering by signing a distribution deal with Olicon ImagingSystems. The deal gives a lift to Olicon, but the San Clemente,CA, firm
Olicon awaits outcome of Du Pont divestiture
Du Pont has expanded its strategy of gaining PACS expertise throughpartnering by signing a distribution deal with Olicon ImagingSystems. The deal gives a lift to Olicon, but the San Clemente,CA, firm may find itself dealing with a new face in the next fewmonths because of Du Pont's decision to sell its Medical Productsgroup (SCAN 6/7/95).
Under the terms of the deal, Du Pont will distribute PACS productsdeveloped by Olicon on a nonexclusive basis. Du Pont has similaragreements with ISG Technologies and Cemax, although the Cemaxagreement may have to be renegotiated due to that firm's evolutioninto Cemax-Icon (SCAN 6/21/95).
Du Pont is interested in the entire line of Olicon products,according to Olicon CEO Dick Paulsen. The two firms will integrateOlicon's offerings with Du Pont's Linx networking system via theACR-NEMA's DICOM 3.0 standard.
The timing of the deal is awkward, given Du Pont's recent announcementthat it intends to divest its medical imaging business. But Oliconis optimistic that the new owner of Du Pont's digital imagingunit will seek to maintain the relationship.
"The agreements will pass along with (the new owner),"Paulsen said Like Du Pont, Olicon has been active in developingpartnerships. It has an agreement similar to the Du Pont dealwith a telemedicine firm and is also negotiating a relationshipwith a multimodality vendor, Paulsen said.
The Du Pont/Olicon agreement, and others between film and multimodalitycompanies and smaller software developers, are representativeof a growing trend in the PACS industry, according to MichaelCannavo of Image Management Consultants in Winter Park, FL.
"It reaffirms the need for larger companies to embrace technologiesdeveloped by smaller companies, allowing them to more quicklyrespond to the changes in the marketplace," Cannavo said.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.
